Idiopathic Anaphylaxis

Paul A. Greenberger, Phillip Lieberman*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

45 Scopus citations


Idiopathic anaphylaxis is a perplexing problem that accounts for approximately 30% to 60% of cases of anaphylaxis in ambulatory adults and perhaps 10% of cases in children. Advances in our knowledge of idiopathic anaphylaxis have occurred over the past decade with the elucidation of mast cell activating disorders and the discovery of episodes of anaphylaxis caused by galactose-alpha-1,3-galactose. Most patients do well because fatalities can usually be prevented with proper therapy, and many individuals, for reasons not understood, undergo spontaneous remission.

Original languageEnglish (US)
Pages (from-to)243-250
Number of pages8
JournalJournal of Allergy and Clinical Immunology: In Practice
Issue number3
StatePublished - May 2014


  • Anaphylaxis
  • Galactose-alpha-1,3-galactose
  • Idiopathic anaphylaxis
  • Mast cell activating disorder
  • Mast cell activating syndrome

ASJC Scopus subject areas

  • Immunology and Allergy


Dive into the research topics of 'Idiopathic Anaphylaxis'. Together they form a unique fingerprint.

Cite this